![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Hangzhou Cn, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their significant offerings is Polymyxin B sulfate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2021-287 - Rev 01
This Chemical and TSE Type CEP, issued on October 04, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 203 associated with this CEP further emphasizes